ImmunityBio (IBRX) Price to Sales (2015 - 2026)
Powered by 
Analysis
ImmunityBio (IBRX) Price to Sales (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | ImmunityBio | 8.48 Bn | 8.12 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 180.06 |
| Mar 31, 2026 | 181.72 |
| Dec 31, 2025 | 52.33 |
| Sep 30, 2025 | 75.58 |
| Jun 30, 2025 | 91.48 |
| Mar 31, 2025 | 155.55 |
| Dec 31, 2024 | 236.38 |
| Sep 30, 2024 | 424.54 |
| Jun 30, 2024 | 4,175.87 |
| Mar 31, 2024 | 90,887.71 |
| Dec 31, 2023 | 18,369.43 |
| Sep 30, 2023 | 10,271.39 |
| Jun 30, 2023 | 29,879.84 |
| Mar 31, 2023 | 2,131.27 |
| Dec 31, 2022 | 29,278.84 |
| Sep 30, 2022 | 16,860.27 |
| Jun 30, 2022 | 42,309.13 |
| Mar 31, 2022 | 159,466.96 |
| Dec 31, 2021 | 6,202.07 |
| Sep 30, 2021 | 58,220.07 |